Brain imaging investigation of chemotherapy-induced neurocognitive changes

Research output: Chapter in Book/Report/Conference proceedingChapter

8 Citations (Scopus)

Abstract

Introduction Structural and functional neuroimaging techniques provide a unique opportunity to examine the neural basis for cognitive changes related to cancer and its treatment. While the link between cognitive dysfunction and central nervous system (CNS) cancers (e.g., primary brain tumors, primary CNS lymphoma, brain metastases of cancer in other organ systems, etc.) or non-CNS cancers treated with prophylactic whole-brain radiation seems clear, our understanding of the causes for cognitive changes following chemotherapy for other non-CNS cancers remains much more limited. Research using a variety of neuroimaging modalities has begun to delineate the brain mechanisms for cognitive changes related to cancer and chemotherapy, across a number of cancer subtypes. This chapter will briefly summarize the cognitive domains most likely to be affected following chemotherapy, review the available data relating cognitive performance and structural and functional neuroimaging changes in various cancer populations, and suggest avenues for future work in this area. As clinical efficacy of cancer treatment has improved survivorship, increased awareness has arisen of issues critical to the functioning and quality of life of cancer survivors. Specifically, cognitive impairment related to cancer and its treatment, including radiation, chemotherapy, and hormone therapies, has been a topic of increasing study for 20 years. While more detailed discussion of cognitive studies of changes in function related to cancer treatment can be found elsewhere in this volume, these issues will be briefly summarized here, as they form a major component from which subsequent neuroimaging research has grown.

Original languageEnglish
Title of host publicationCognition and Cancer
PublisherCambridge University Press
Pages19-32
Number of pages14
ISBN (Print)9780511545900, 9780521854825
DOIs
StatePublished - Jan 1 2008

Fingerprint

Neuroimaging
Drug Therapy
Neoplasms
Functional Neuroimaging
Brain Neoplasms
Nervous System
Central Nervous System
Radiation
Second Primary Neoplasms
Brain
Therapeutics
Research
Survivors
Lymphoma
Survival Rate
Quality of Life
Hormones
Neoplasm Metastasis

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Brain imaging investigation of chemotherapy-induced neurocognitive changes. / McDonald, Brenna; Saykin, Andrew; Ahles, Tim A.

Cognition and Cancer. Cambridge University Press, 2008. p. 19-32.

Research output: Chapter in Book/Report/Conference proceedingChapter

McDonald, Brenna ; Saykin, Andrew ; Ahles, Tim A. / Brain imaging investigation of chemotherapy-induced neurocognitive changes. Cognition and Cancer. Cambridge University Press, 2008. pp. 19-32
@inbook{c7ed39aad3294909afd254cf1434f9e5,
title = "Brain imaging investigation of chemotherapy-induced neurocognitive changes",
abstract = "Introduction Structural and functional neuroimaging techniques provide a unique opportunity to examine the neural basis for cognitive changes related to cancer and its treatment. While the link between cognitive dysfunction and central nervous system (CNS) cancers (e.g., primary brain tumors, primary CNS lymphoma, brain metastases of cancer in other organ systems, etc.) or non-CNS cancers treated with prophylactic whole-brain radiation seems clear, our understanding of the causes for cognitive changes following chemotherapy for other non-CNS cancers remains much more limited. Research using a variety of neuroimaging modalities has begun to delineate the brain mechanisms for cognitive changes related to cancer and chemotherapy, across a number of cancer subtypes. This chapter will briefly summarize the cognitive domains most likely to be affected following chemotherapy, review the available data relating cognitive performance and structural and functional neuroimaging changes in various cancer populations, and suggest avenues for future work in this area. As clinical efficacy of cancer treatment has improved survivorship, increased awareness has arisen of issues critical to the functioning and quality of life of cancer survivors. Specifically, cognitive impairment related to cancer and its treatment, including radiation, chemotherapy, and hormone therapies, has been a topic of increasing study for 20 years. While more detailed discussion of cognitive studies of changes in function related to cancer treatment can be found elsewhere in this volume, these issues will be briefly summarized here, as they form a major component from which subsequent neuroimaging research has grown.",
author = "Brenna McDonald and Andrew Saykin and Ahles, {Tim A.}",
year = "2008",
month = "1",
day = "1",
doi = "10.1017/CBO9780511545900.004",
language = "English",
isbn = "9780511545900",
pages = "19--32",
booktitle = "Cognition and Cancer",
publisher = "Cambridge University Press",

}

TY - CHAP

T1 - Brain imaging investigation of chemotherapy-induced neurocognitive changes

AU - McDonald, Brenna

AU - Saykin, Andrew

AU - Ahles, Tim A.

PY - 2008/1/1

Y1 - 2008/1/1

N2 - Introduction Structural and functional neuroimaging techniques provide a unique opportunity to examine the neural basis for cognitive changes related to cancer and its treatment. While the link between cognitive dysfunction and central nervous system (CNS) cancers (e.g., primary brain tumors, primary CNS lymphoma, brain metastases of cancer in other organ systems, etc.) or non-CNS cancers treated with prophylactic whole-brain radiation seems clear, our understanding of the causes for cognitive changes following chemotherapy for other non-CNS cancers remains much more limited. Research using a variety of neuroimaging modalities has begun to delineate the brain mechanisms for cognitive changes related to cancer and chemotherapy, across a number of cancer subtypes. This chapter will briefly summarize the cognitive domains most likely to be affected following chemotherapy, review the available data relating cognitive performance and structural and functional neuroimaging changes in various cancer populations, and suggest avenues for future work in this area. As clinical efficacy of cancer treatment has improved survivorship, increased awareness has arisen of issues critical to the functioning and quality of life of cancer survivors. Specifically, cognitive impairment related to cancer and its treatment, including radiation, chemotherapy, and hormone therapies, has been a topic of increasing study for 20 years. While more detailed discussion of cognitive studies of changes in function related to cancer treatment can be found elsewhere in this volume, these issues will be briefly summarized here, as they form a major component from which subsequent neuroimaging research has grown.

AB - Introduction Structural and functional neuroimaging techniques provide a unique opportunity to examine the neural basis for cognitive changes related to cancer and its treatment. While the link between cognitive dysfunction and central nervous system (CNS) cancers (e.g., primary brain tumors, primary CNS lymphoma, brain metastases of cancer in other organ systems, etc.) or non-CNS cancers treated with prophylactic whole-brain radiation seems clear, our understanding of the causes for cognitive changes following chemotherapy for other non-CNS cancers remains much more limited. Research using a variety of neuroimaging modalities has begun to delineate the brain mechanisms for cognitive changes related to cancer and chemotherapy, across a number of cancer subtypes. This chapter will briefly summarize the cognitive domains most likely to be affected following chemotherapy, review the available data relating cognitive performance and structural and functional neuroimaging changes in various cancer populations, and suggest avenues for future work in this area. As clinical efficacy of cancer treatment has improved survivorship, increased awareness has arisen of issues critical to the functioning and quality of life of cancer survivors. Specifically, cognitive impairment related to cancer and its treatment, including radiation, chemotherapy, and hormone therapies, has been a topic of increasing study for 20 years. While more detailed discussion of cognitive studies of changes in function related to cancer treatment can be found elsewhere in this volume, these issues will be briefly summarized here, as they form a major component from which subsequent neuroimaging research has grown.

UR - http://www.scopus.com/inward/record.url?scp=77349124166&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77349124166&partnerID=8YFLogxK

U2 - 10.1017/CBO9780511545900.004

DO - 10.1017/CBO9780511545900.004

M3 - Chapter

AN - SCOPUS:77349124166

SN - 9780511545900

SN - 9780521854825

SP - 19

EP - 32

BT - Cognition and Cancer

PB - Cambridge University Press

ER -